Glenmark has received permission from the Food and Drug Administration for Tacrolimus Ointment, 0.03%, the generic of Leo Pharma's Protopic. Protopic Ointment, both 0.03% and 0.1% for adults, and only ...

Jan. 19, 2006 — The US Food and Drug Administration (FDA) has approved revisions to the safety labeling for 1% pimecrolimus cream ( Elidel, made by Novartis Pharmaceuticals Corporation) and tacrolimus ...

Perrigo announced the availability of Tacrolimus Ointment, the generic version of Astellas’ Protopic Ointment. Protopic is an immunomodulator that is indicated as second-line therapy for short-term ...

Mumbai: Glenmark Pharmaceuticals Ltd., a pharmaceutical firm, has obtained final endorsement from the United States Food and Drug Administration (USFDA) for its Tacrolimus ointment, 0.03 per cent.

March 11, 2005 -- The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and patients via public health advisory of the potential cancer risk associated with use of ...

The Food and Drug Administration has announced that the labels for two eczema drugs -- Elidel cream and Protopic ointment -- will now include warnings about a possible risk of cancer, as well as a ...

Can protopic cream be used for hyper pigmentation and does it work also what treatments are available for this condition. Answer::Hallo Cindy No it only works for inflammation of the skin like eczema.

Glenmark Pharmaceuticals Limited, a research‐led, integrated, global pharmaceutical company has received final approval by the United States Food & Drug Administration (U.S. FDA) Tacrolimus Ointment, ...

Dermatology leaders rallied to the defence of Novartis' Elidel (pimecrolimus), a topical cream for atopic eczema, this week during the 8th Congress of the European Society for Pediatric Dermatology in ...

Two eczema creams — Novartis AG’s Elidel and Fujisawa Healthcare, Inc.’s Protopic, must carry a strong warning of cancer risk, the Food and Drug Administration said Thursday. Research shows the creams ...

The labels on two prescription creams to treat eczema will have to bear “black box” warnings of possible cancer risks. The Food and Drug Administration action on Thursday follows an agency advisory ...